MEI Pharma issued European patent for ME-344

[Other] – Novogen Limited’s subsidiary, Marshall Edwards, Inc., (NASDAQ: MEIP), has made the following announcement: San Diego – 2 October, 2012 – MEI Pharma, Inc., an oncology company focused on the clinical development … more

View todays social media effects on MEIP

View the latest stocks trending across Twitter. Click to view dashboard